

Check if a pharmacy near you has Difluprednate in stock without calling. Use Medfinder, pharmacy apps, and other tools to find availability fast.
You've got a prescription for Difluprednate (Durezol), and now you need to actually fill it. But with the ongoing Difluprednate shortage, that's easier said than done. Calling pharmacy after pharmacy gets old fast — especially when you're dealing with eye inflammation or recovering from surgery.
The good news: there are ways to check stock without picking up the phone. Here's how.
Difluprednate has been in an active shortage since April 2024, when generic manufacturer Exelan placed its 0.05% ophthalmic emulsion on long-term back order with no estimated release date. This has pushed more patients toward brand-name Durezol, straining supply further.
The result? Your usual pharmacy may not have it. But other pharmacies in your area — or online options — might. You just need to know where to look. For a full breakdown, read our guide on why Difluprednate is hard to find.
Medfinder is the fastest way to check Difluprednate availability near you. Simply enter your medication and location, and Medfinder shows you which pharmacies currently have it in stock — no phone calls needed.
This is especially helpful during a shortage because Medfinder tracks real-time availability across multiple pharmacies, saving you the hassle of checking one by one.
Many large pharmacy chains let you check stock or transfer prescriptions online:
While GoodRx is primarily known for discount coupons, it also shows which pharmacies in your area carry a specific medication and at what price. Search for "Difluprednate" on goodrx.com and enter your ZIP code. The results will show nearby pharmacies with pricing — if a pharmacy lists a price, it generally has the medication available or can order it.
Online pharmacies can sometimes source medications that local stores can't:
Because Difluprednate is an ophthalmic medication, some specialty pharmacies or pharmacies affiliated with eye clinics may have better access to supply. Ask your ophthalmologist's office if they have an in-house pharmacy or a preferred specialty pharmacy they work with.
Sometimes a quick phone call is the most direct route. Here are tips to make it efficient:
When you locate a pharmacy with Difluprednate in stock, act quickly — during a shortage, supplies can sell out fast. Here's what to do:
If your prescription is at a pharmacy that's out of stock, you can transfer it. Most pharmacies can handle this over the phone. Just call the pharmacy that has Difluprednate and give them your current pharmacy's information. They'll take care of the rest.
Prices for Difluprednate vary widely. Brand-name Durezol can cost $250–$400 without insurance, while generic versions with a discount card may be $45–$120. Before filling, check our guide on how to save money on Difluprednate to find the best price.
During shortages, some pharmacies limit quantities to ensure more patients can access the medication. If you need more than one bottle, ask about their policy.
If you'll need ongoing Difluprednate, ask the pharmacy to set up automatic refill notifications. This gives them advance notice to order your medication before you run out.
Finding Difluprednate in stock during a shortage takes a bit of extra effort, but you don't have to spend hours on the phone. Tools like Medfinder, pharmacy apps, and online services can help you locate it quickly.
If you're completely unable to find Difluprednate, talk to your ophthalmologist about alternative medications like Prednisolone Acetate (Pred Forte) or Loteprednol (Lotemax) that might work for your condition.
Don't let a shortage delay your treatment. Start checking today.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.